Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Suboptimal/Reduced Therapy in Older Patients with T-Cell Lymphoma Resulted in Poorer Outcomes: Report from the International T-Cell Project 1.0

Tetiana Skrypets, Onder Alpdogan, Luana Conte, Monica Civallero, Athina Lymboussaki, Julie M. Vose, Ivan Dlouhy, Maria Elena Cabrera, Felicitas Hitz, Sabela Bobillo, Won Seog Kim, Arnon Nagler, Dario Marino, Ranjana H. Advani, Caterina Stelitano, Pierluigi Porcu, Massimo Federico

Blood (2024) 144 (Supplement 1): 6402.

https://doi.org/10.1182/blood-2024-203976

Published: 2024

Journal Articles

Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Blood (2022) 140 (Supplement 1): 1476–1478.

https://doi.org/10.1182/blood-2022-158883

Published: 2022

Journal Articles

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

Ranjana H. Advani, Tetiana Skrypets, Monica Civallero, Michael A. Spinner, Martina Manni, Won Seog Kim, Andrei R. Shustov, Steven M. Horwitz, Felicitas Hitz, Maria Elena Cabrera, Ivan Dlouhy, José Vassallo, Stefano A. Pileri, Giorgio Inghirami, Silvia Montoto, Umberto Vitolo, John Radford, Julie M. Vose, Massimo Federico

Blood (2021) 138 (3): 213–220.

https://doi.org/10.1182/blood.2020010387

Published: 2021

Includes: Supplemental data

Journal Articles

Distinct molecular profile of IRF4 -rearranged large B-cell lymphoma

Blood (2020) 135 (4): 274–286.

https://doi.org/10.1182/blood.2019002699

Published: 2020

Includes: Supplemental data

Journal Articles

"Real-World" Peripheral T-Cell Lymphomas Experience in Portugal: Is There Reason for Optimism?

Ivan Dlouhy, Rita Gavancha, MD, Inês Coelho, MD, Catalina Gomez, MD, Inês Barbosa, MD, Susana Carvalho, MD, Maria Ceu Trindade, MD, Ana Filipa Moita, Gonçalo Esteves, MD, Paula Gameiro, Jose Cabecadas, Maria Silva, MD

Blood (2019) 134 (Supplement_1): 5287.

https://doi.org/10.1182/blood-2019-124485

Published: 2019

Journal Articles

Mutational Landscape, Copy Number Alterations and Tumor Burden Assessed By Cell-Free DNA in Diffuse Large B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 4110.

https://doi.org/10.1182/blood-2019-128813

Published: 2019

Journal Articles

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts

Blood (2018) 132 (Supplement 1): 1567.

https://doi.org/10.1182/blood-2018-99-114493

Published: 2018

Journal Articles

Peripheral T-Cell Lymphomas in Spain: Profiling Clinical, Phenotypic and Genetic Characteristics in Spanish Population

Blood (2018) 132 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2018-99-116562

Published: 2018

Journal Articles

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Blood (2017) 130 (Supplement 1): 2008.

https://doi.org/10.1182/blood.V130.Suppl_1.2008.2008

Published: 2017

Journal Articles

Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era

Blood (2017) 130 (Supplement 1): 827.

https://doi.org/10.1182/blood.V130.Suppl_1.827.827

Published: 2017

Journal Articles

Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project

Blood (2017) 130 (Supplement 1): 1512.

https://doi.org/10.1182/blood.V130.Suppl_1.1512.1512

Published: 2017

Journal Articles

Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets

Blood (2016) 128 (22): 152.

https://doi.org/10.1182/blood.V128.22.152.152

Published: 2016

Journal Articles

Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

Laura Magnano, MD, Ivan Dlouhy, MD, Olga Balagué, MD, Alfredo Rivas-Delgado, MD, Jordina Rovira, MD, Kennosuke Karube, MD PhD, Blanca Gonzalez, MD, Alejandra Martinez-Trillos, MD, Antonio Martínez, MD PhD, Julio Delgado, Eva Gine, Neus Villamor, MD PhD, Elias Campo, MD PhD, Armando Lopez-Guillermo

Blood (2016) 128 (22): 3043.

https://doi.org/10.1182/blood.V128.22.3043.3043

Published: 2016

Journal Articles

Lenalidomide in Combination with R-ESHAP (LR-ESHAP) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Are Candidates for Autologous Stem-Cell Transplantation: A Phase 2 Study from the Spanish Group Geltamo

Alejandro Martín, MD PhD, Mónica Baile, MD, Guillermo Rodríguez, MD, Ivan Dlouhy, MD, Juan Manuel Sancho, MD PhD, Isidro Jarque, MD, Eva González-Barca, MD PhD, Antonio Salar, MD PhD, Manuel Espeso, Carlos Grande, MD PhD, Juan Bergua, MD, Santiago Montes-Moreno, MD, Armando Lopez-Guillermo, Dolores Caballero, MD PhD

Blood (2016) 128 (22): 1850.

https://doi.org/10.1182/blood.V128.22.1850.1850

Published: 2016

Journal Articles

The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project

Monica Bellei, Francine M Foss, MD, Steven M Horwitz, MD, Luigi Marcheselli, Won Seong Kim, Maria Elena Cabrera, Ivan Dlouhy, MD, Arnon Nagler, Ranjana H Advani, MD, Emanuela Pesce, Young Hyeh Ko, MD, Virginia Martinez, Silvia Montoto, MD, Carlos Chiattone, Alison J. Moskowitz, MD, Michele Spina, Marina Cesaretti, Irene Biasoli, Massimo Federico

Blood (2016) 128 (22): 921.

https://doi.org/10.1182/blood.V128.22.921.921

Published: 2016

Journal Articles

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Blood (2013) 122 (21): 369.

https://doi.org/10.1182/blood.V122.21.369.369

Published: 2013

Journal Articles

The Pretreatment Absolute Lymphocyte Count (ALC), but Not the Absolute Monocyte Count (AMC) or ALC/AMC Ratio, Is an Independent Prognostic Factor in Aggressive Non-Hodgkin Lymphoma (aNHL)

Noridza Rivera-Rodriguez, MD, Fernando Cabanillas, MD, Carlos Montalban, Jose Francisco Tomas, MD, María José Terol, MD, PhD, Armando López-Guillermo, MD, Wandaly I. Pardo, MD, Orestes A. Pavia, MD, Margarita Bruno, MD, Karen Janice Santiago, Pablo Guisado-Vasco, MD, PhD, Angel Ruedas, MD, Raquel de Oña, Silvia Solorzano, Ana Isabel Teruel, MD, Laura Garcia-Sanchis, Jordina Rovira, MD, Ivan Dlouhy

Blood (2012) 120 (21): 1596.

https://doi.org/10.1182/blood.V120.21.1596.1596

Published: 2012

Journal Articles

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Julio Delgado, Itziar Salaverría, Eriong Lee, Laura Jiménez, Alba Navarro, Dolors Colomer, Ivan Dlouhy, Laura Conde, Alejandra Martinez-Trillos, Cristina Lopez, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, María Rozman, Eva Giné, Dolors Costa, Anna Carrió, Armando López-Guillermo, Elías Campo, Sílvia Beà

Blood (2012) 120 (21): 4577.

https://doi.org/10.1182/blood.V120.21.4577.4577

Published: 2012

Journal Articles

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Gabriela Ghita, MD, Julio Delgado, MD. PhD, Tycho Baumann, MD, Ivan Dlouhy, MD, Marta Aymerich, MD. PhD, Dolors Colomer, MD. PhD, María Rozman, Neus Villamor, MD. PhD, Natalia Creus, MD. PhD, Arturo Pereira, MD. PhD, Emili Montserrat, MD. PhD

Blood (2011) 118 (21): 3908.

https://doi.org/10.1182/blood.V118.21.3908.3908

Published: 2011

NARROW

Suboptimal/Reduced Therapy in Older Patients with T-Cell Lymphoma Resulted in Poorer Outcomes: Report from the International T-Cell Project 1.0

Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

Distinct molecular profile of IRF4 -rearranged large B-cell lymphoma

"Real-World" Peripheral T-Cell Lymphomas Experience in Portugal: Is There Reason for Optimism?

Mutational Landscape, Copy Number Alterations and Tumor Burden Assessed By Cell-Free DNA in Diffuse Large B-Cell Lymphoma

Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts

Peripheral T-Cell Lymphomas in Spain: Profiling Clinical, Phenotypic and Genetic Characteristics in Spanish Population

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era

Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project

Integrating Genomic Alterations in Diffuse Large B-Cell Lymphoma Identifies New Relevant Pathways and Potential Therapeutic Targets

Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)

Lenalidomide in Combination with R-ESHAP (LR-ESHAP) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Are Candidates for Autologous Stem-Cell Transplantation: A Phase 2 Study from the Spanish Group Geltamo

The Outcome of Patients with Primary Refractory or Relapsed Peripheral T-Cell Lymphoma: Analysis of 1020 Cases Registered in the Prospective T-Cell Project

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

The Pretreatment Absolute Lymphocyte Count (ALC), but Not the Absolute Monocyte Count (AMC) or ALC/AMC Ratio, Is an Independent Prognostic Factor in Aggressive Non-Hodgkin Lymphoma (aNHL)

Detailed Molecular Analysis of Patients with Chronic Lymphocytic Leukemia Carrying 17p Deletions Reveals Concurrent Abnormalities with Prognostic Impact

Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only